Browsing by Author Buxton, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)
9-Jun-2021Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?Cubi-Molla, P; Buxton, M; Devlin, N
2012Bayesian meta-analysis on medical devices: Application to implantable cardioverter defibrillatorsYoun, J-H; Lord, J; Hemming, K; Girling, A; Buxton, M
2012Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trialSharples, LD; Jackson, C; Wheaton, E; Griffith, G; Annema, JT; Dooms, C; Tournoy, KG; Deschepper, E; Hughes, V; Magee, L; Buxton, M; Rintoul, RC
2014Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: Mid-term outcomes from the CECaT randomised controlled trialThom, H; Jackson, CH; West, NEJ; Hughes, V; Dyer, M; Buxton, M; Sharples, LD; Crean, AM
2004The development and application of a normative framework for considering uncertainty and variability in economic evaluationCoyle, Douglas
2012Does responsibility affect the public valuation of health care interventions? A relative valuation approach to health care safetySingh, J; Lord, J; Longworth, L; Orr, S; McGarry, T; Sheldon, R; Buxton, M
2004Estimating the economic value to societies of the impact of health research: A critical reviewBuxton, M; Hanney, S; Jones, T
2014Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomesBuxton, M; Guthrie, S; Hanney, SR; Pollitt, A; Grant, J
2014Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomesGlover, M; Buxton, M; Guthrie, S; Hanney, S; Pollitt, A; Grant, J
2017Estimating the Returns to United Kingdom Publicly Funded Musculoskeletal Disease Research in Terms of Net Value of Improved Health OutcomesGlover, M; Montague, E; Pollitt, A; Guthrie, S; Hanney, S; Buxton, M; Grant, J
2013EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healingYang, Y; Glover, M; Bayliss, S; Pokhrel, S; Lord, J; Buxton, M
2013Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choicesSingh, J; Longworth, L; Baine, A; Lord, J; Orr, S; Buxton, M
2013Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choicesSingh, J; Longworth, L; Baine, A; Lord, J; Orr, S; Buxton, M
2013Physical activity in England: Who is meeting the recommended level of participation through sports and exercise?Anokye, NK; Pokhrel, S; Buxton, M; Fox-Rushby, J
2008Prioritisation of prevention services: Determining the applicability of research from the US to the English contextFox-Rushby, J; Boehler, C; Hanney, S; Roberts, I; Beresford, P; Buxton, M
2014Reforming the cancer drug fund focus on drugs that might be shown to be cost effectiveBuxton, M; Longworth, L; Raftery, J; Sculpher, M; Towse, A